|
|
 |
|
Viewing report
|
|
|
|
Adult Stem Cells and iPSCs 2010 Market Report
Select Biosciences Ltd, March 2010, Pages: 204
This market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie the majority of cellular therapeutics that are under development worldwide and this market report maps this landscape with particular emphasis on the characteristics of adult stem cells which leverage their utilization for cellular therapy/regenerative medicine.
This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our deep analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the Space for Adult Stem Cells as wells as for iPSCs.
In this market report, we provide a technical, market (global research trends), intellectual property, and a regulatory map of the iPSC space that is granular and up-to-date.
Specific Topics Covered in this Report:
- Qualitative and Quantitative Trends in the Adult and iPSCs Space: Quantitative Market Forecast (Market Size) by Product Class in the Stem Cells Space and Corresponding Growth Rates
- Primary Market Survey Data Derived from a Worldwide Pool of Industry Participants Presents the Market Landscape for iPSCs
- Worldwide Intellectual Property (IP) Landscape for iPSCs as its Exists Today: Presents the Scope of the Issued IP as well as filings in various aspects of iPSC production—Important for Benchmarking Research & Development Programs
- Regulatory Landscape of iPSCs Across the European Union
- Therapeutic Areas Impacted by Adult Stem Cells
- Mesenchymal Stem Cells (MSCs) for Cellular Therapy: Detailed Presentation of the MSC Space From a Technical Perspective: Phenotype, Characteristics, Mechanisms of Action
This data-driven characterization of the stem cells landscape as it relates to adult stem cells and iPSCs is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.
Extensive Worldwide Technical and Market Analyses Presented in this Report:
- Worldwide Total Quantitative Market Opportunity and Growth in the Stem Cells Space
- Mesenchymal Stem Cells [MSCs] for Cellular Therapy/Regenerative Medicine
- Mechanism of Action of MSCs in Cellular Therapy/Regenerative Medicine: Mechanism of MSC-mediated Tissue Repair
- Clinical Trials Deploying MSCs in Various Therapeutic Areas: Quantitative Market Breakout and Characteristics
- Other Types of Adult Stem Cells and their Penetrance in Cellular Therap
- Business Models in the Cellular Therapy Space
- Cellular Therapy of Cardiovascular and CNS Diseases: Market Characteristics
- iPSCs: Technical Characteristics, Current Worldwide Research Market Trends
- iPSCs: Intellectual Property (IP) Landscape Analysis with Description of Scope of Filed IP and Issued IP
- iPSCs: Regulatory Trends Across the European Union (EU)
- More details of the scope of coverage of this industry report are found in the Table of Contents (TOC) for the report—see below for link to downloadable PDF of the TOC
This data-driven characterization of the microRNA research landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.
Customers who bought this item also bought
Stem Cells for Cellular Therapy 2010 Market Report
Cell Therapy - Technologies, Markets and Companies
Stem Cells for Cardiovascular Disease 2009 Market Report
Adult Stem Cells Market Trends 2011
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine
Epigenetics, Pluripotency, and Reprogramming 2009
Stem Cell Research Products: Opportunities, Tools & Technologies 2012 (Updated)
Gene Therapy - Technologies, Markets and Companies
Stem Cells Research - Global Strategic Business Report
Progenitor and Stem Cell Technologies and Therapies
|
|
|
|
